Kenya AIDS Vaccine Initiative

Nairobi

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections

Studies at this site

• A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults — Completed